# Umbilical Cord Derived Mesenchymal Stromal Cells For The Treatment of Severe Steroid-resistant Graft Versus Host Disease

> **NCT02032446** · PHASE1,PHASE2 · UNKNOWN · sponsor: **A.O. Ospedale Papa Giovanni XXIII** · enrollment: 47 (estimated)

## Conditions studied

- Hematologic Malignancies

## Interventions

- **BIOLOGICAL:** UMBILICAL CORD DERIVED MESENCHYMAL STROMAL CELLS (UC-MSC)

## Key facts

- **NCT ID:** NCT02032446
- **Lead sponsor:** A.O. Ospedale Papa Giovanni XXIII
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2013-09
- **Primary completion:** 2016-09
- **Final completion:** 2019-09
- **Target enrollment:** 47 (ESTIMATED)
- **Last updated:** 2019-01-18

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02032446

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02032446, "Umbilical Cord Derived Mesenchymal Stromal Cells For The Treatment of Severe Steroid-resistant Graft Versus Host Disease". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02032446. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*